Loading…

Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine

Saved in:

Bibliographic Details
Published in:	La revue de medecine interne 2005-10, Vol.26 (10), p.835
Main Authors:	Leclercq, V, Lacaille, S, Delpierre, S, Karoubi, E, Legrain, S
Format:	Article
Language:	fre
Subjects:	Aged Aged, 80 and over Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antimanic Agents - administration & dosage Antimanic Agents - adverse effects Antimanic Agents - therapeutic use Bipolar Disorder - complications Bipolar Disorder - drug therapy Brain Diseases - chemically induced Brain Diseases - diagnosis Bronchitis - complications Bronchitis - drug therapy Carbamazepine - administration & dosage Carbamazepine - adverse effects Carbamazepine - therapeutic use Clarithromycin - administration & dosage Clarithromycin - therapeutic use Drug Interactions Electroencephalography Humans Iatrogenic Disease Male Time Factors
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page
container_issue	10
container_start_page	835
container_title	La revue de medecine interne
container_volume	26
creator	Leclercq, V Lacaille, S Delpierre, S Karoubi, E Legrain, S
description
doi_str_mv	10.1016/j.revmed.2005.05.014
format	article
fullrecord	<record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_16023268</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16023268</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-8ab684b2fd8ef12733e19c7c90921972f6ce43c0967c239a099ddc6c5e021593</originalsourceid><addsrcrecordid>eNo1j9FKwzAYhXOhuDl9A5G8QOufpEsT78bQKQy8Gd6ONPlrM9q0pF2lPr0VFQ4czuFw4CPkjkHKgMmHUxpxbNClHGCd_ohlF2QJPFOJklIsyHXfnwBgXusrsmASuOBSLcn7Zmy9M0WN1LgRY48URwzDI7UmFqYxX9j5MJfBYleZuu3MUE30s8JAfRhi687Whw9qaxP9UMW2meaMN-SyNHWPt3--Iofnp8P2Jdm_7V63m33SMVBDokwhVVbw0iksGc-FQKZtbjVoznTOS2kxExa0zC0X2oDWzllp1wicrbVYkfvf2-5czPjHLvrGxOn4zye-AdLsVAI</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine</title><source>Elsevier</source><creator>Leclercq, V ; Lacaille, S ; Delpierre, S ; Karoubi, E ; Legrain, S</creator><creatorcontrib>Leclercq, V ; Lacaille, S ; Delpierre, S ; Karoubi, E ; Legrain, S</creatorcontrib><identifier>ISSN: 0248-8663</identifier><identifier>DOI: 10.1016/j.revmed.2005.05.014</identifier><identifier>PMID: 16023268</identifier><language>fre</language><publisher>France</publisher><subject>Aged ; Aged, 80 and over ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - therapeutic use ; Antimanic Agents - administration & dosage ; Antimanic Agents - adverse effects ; Antimanic Agents - therapeutic use ; Bipolar Disorder - complications ; Bipolar Disorder - drug therapy ; Brain Diseases - chemically induced ; Brain Diseases - diagnosis ; Bronchitis - complications ; Bronchitis - drug therapy ; Carbamazepine - administration & dosage ; Carbamazepine - adverse effects ; Carbamazepine - therapeutic use ; Clarithromycin - administration & dosage ; Clarithromycin - therapeutic use ; Drug Interactions ; Electroencephalography ; Humans ; Iatrogenic Disease ; Male ; Time Factors</subject><ispartof>La revue de medecine interne, 2005-10, Vol.26 (10), p.835</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16023268$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leclercq, V</creatorcontrib><creatorcontrib>Lacaille, S</creatorcontrib><creatorcontrib>Delpierre, S</creatorcontrib><creatorcontrib>Karoubi, E</creatorcontrib><creatorcontrib>Legrain, S</creatorcontrib><title>Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine</title><title>La revue de medecine interne</title><addtitle>Rev Med Interne</addtitle><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antimanic Agents - administration & dosage</subject><subject>Antimanic Agents - adverse effects</subject><subject>Antimanic Agents - therapeutic use</subject><subject>Bipolar Disorder - complications</subject><subject>Bipolar Disorder - drug therapy</subject><subject>Brain Diseases - chemically induced</subject><subject>Brain Diseases - diagnosis</subject><subject>Bronchitis - complications</subject><subject>Bronchitis - drug therapy</subject><subject>Carbamazepine - administration & dosage</subject><subject>Carbamazepine - adverse effects</subject><subject>Carbamazepine - therapeutic use</subject><subject>Clarithromycin - administration & dosage</subject><subject>Clarithromycin - therapeutic use</subject><subject>Drug Interactions</subject><subject>Electroencephalography</subject><subject>Humans</subject><subject>Iatrogenic Disease</subject><subject>Male</subject><subject>Time Factors</subject><issn>0248-8663</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNo1j9FKwzAYhXOhuDl9A5G8QOufpEsT78bQKQy8Gd6ONPlrM9q0pF2lPr0VFQ4czuFw4CPkjkHKgMmHUxpxbNClHGCd_ohlF2QJPFOJklIsyHXfnwBgXusrsmASuOBSLcn7Zmy9M0WN1LgRY48URwzDI7UmFqYxX9j5MJfBYleZuu3MUE30s8JAfRhi687Whw9qaxP9UMW2meaMN-SyNHWPt3--Iofnp8P2Jdm_7V63m33SMVBDokwhVVbw0iksGc-FQKZtbjVoznTOS2kxExa0zC0X2oDWzllp1wicrbVYkfvf2-5czPjHLvrGxOn4zye-AdLsVAI</recordid><startdate>200510</startdate><enddate>200510</enddate><creator>Leclercq, V</creator><creator>Lacaille, S</creator><creator>Delpierre, S</creator><creator>Karoubi, E</creator><creator>Legrain, S</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>200510</creationdate><title>Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine</title><author>Leclercq, V ; Lacaille, S ; Delpierre, S ; Karoubi, E ; Legrain, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-8ab684b2fd8ef12733e19c7c90921972f6ce43c0967c239a099ddc6c5e021593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2005</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antimanic Agents - administration & dosage</topic><topic>Antimanic Agents - adverse effects</topic><topic>Antimanic Agents - therapeutic use</topic><topic>Bipolar Disorder - complications</topic><topic>Bipolar Disorder - drug therapy</topic><topic>Brain Diseases - chemically induced</topic><topic>Brain Diseases - diagnosis</topic><topic>Bronchitis - complications</topic><topic>Bronchitis - drug therapy</topic><topic>Carbamazepine - administration & dosage</topic><topic>Carbamazepine - adverse effects</topic><topic>Carbamazepine - therapeutic use</topic><topic>Clarithromycin - administration & dosage</topic><topic>Clarithromycin - therapeutic use</topic><topic>Drug Interactions</topic><topic>Electroencephalography</topic><topic>Humans</topic><topic>Iatrogenic Disease</topic><topic>Male</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leclercq, V</creatorcontrib><creatorcontrib>Lacaille, S</creatorcontrib><creatorcontrib>Delpierre, S</creatorcontrib><creatorcontrib>Karoubi, E</creatorcontrib><creatorcontrib>Legrain, S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>La revue de medecine interne</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leclercq, V</au><au>Lacaille, S</au><au>Delpierre, S</au><au>Karoubi, E</au><au>Legrain, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine</atitle><jtitle>La revue de medecine interne</jtitle><addtitle>Rev Med Interne</addtitle><date>2005-10</date><risdate>2005</risdate><volume>26</volume><issue>10</issue><spage>835</spage><pages>835-</pages><issn>0248-8663</issn><cop>France</cop><pmid>16023268</pmid><doi>10.1016/j.revmed.2005.05.014</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 0248-8663
ispartof	La revue de medecine interne, 2005-10, Vol.26 (10), p.835
issn	0248-8663
language	fre
recordid	cdi_pubmed_primary_16023268
source	Elsevier
subjects	Aged Aged, 80 and over Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antimanic Agents - administration & dosage Antimanic Agents - adverse effects Antimanic Agents - therapeutic use Bipolar Disorder - complications Bipolar Disorder - drug therapy Brain Diseases - chemically induced Brain Diseases - diagnosis Bronchitis - complications Bronchitis - drug therapy Carbamazepine - administration & dosage Carbamazepine - adverse effects Carbamazepine - therapeutic use Clarithromycin - administration & dosage Clarithromycin - therapeutic use Drug Interactions Electroencephalography Humans Iatrogenic Disease Male Time Factors
title	Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A22%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Avoidable%20adverse%20event:%20carbamazepine%20encephalopathy%20when%20introducing%20clarithromycine&rft.jtitle=La%20revue%20de%20medecine%20interne&rft.au=Leclercq,%20V&rft.date=2005-10&rft.volume=26&rft.issue=10&rft.spage=835&rft.pages=835-&rft.issn=0248-8663&rft_id=info:doi/10.1016/j.revmed.2005.05.014&rft_dat=%3Cpubmed%3E16023268%3C/pubmed%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p108t-8ab684b2fd8ef12733e19c7c90921972f6ce43c0967c239a099ddc6c5e021593%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/16023268&rfr_iscdi=true